Literature DB >> 12551894

Secretory vesicular transport from the Golgi is altered during ATP-binding cassette protein A1 (ABCA1)-mediated cholesterol efflux.

Xiaohui Zha1, Andre Gauthier, Jacques Genest, Ruth McPherson.   

Abstract

Apolipoprotein AI (apoAI)-mediated cholesterol efflux is a process by which cells export excess cellular cholesterol to apoAI to form high density lipoprotein. ATP-binding cassette protein A1 (ABCA1) has recently been identified as the key regulator of this process. The pathways of intracellular cholesterol transport during efflux are largely unknown nor is the molecular mechanism by which ABCA1 governs cholesterol efflux well understood. Here, we report that, in both macrophages and fibroblasts, the secretory vesicular transport changes in response to apoAI-mediated cholesterol efflux. Vesicular transport from the Golgi to the plasma membrane increased 2-fold during efflux. This increase in vesicular transport during efflux was observed in both raft-poor and raft-rich vesicle populations originated from the Golgi. Importantly, enhanced vesicular transport in response to apoAI is absent in Tangier fibroblasts, a cell type with deficient cholesterol efflux due to functional ABCA1 mutations. These findings are consistent with an efflux model whereby cholesterol is transported from the storage site to the plasma membrane via the Golgi. ABCA1 may influence cholesterol efflux in part by enhancing vesicular trafficking from the Golgi to the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12551894     DOI: 10.1074/jbc.C300024200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Characterization of apoA-I-dependent lipid efflux from adipocytes and role of ABCA1.

Authors:  Alisha D Howard; Philip B Verghese; Estela L Arrese; Jose L Soulages
Journal:  Mol Cell Biochem       Date:  2010-06-10       Impact factor: 3.396

Review 2.  Reverse cholesterol transport: high-density lipoprotein's magnificent mile.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 3.  The role of vesicular transport in ABCA1-dependent lipid efflux and its connection with NPC pathways.

Authors:  Emmanuel Boadu; Gordon A Francis
Journal:  J Mol Med (Berl)       Date:  2005-11-17       Impact factor: 4.599

4.  Origins of intestinal ABCA1-mediated HDL-cholesterol.

Authors:  F Jeffrey Field; Kim Watt; Satya N Mathur
Journal:  J Lipid Res       Date:  2008-08-18       Impact factor: 5.922

Review 5.  Is ABCA1 a lipid transfer protein?

Authors:  Michael C Phillips
Journal:  J Lipid Res       Date:  2018-01-05       Impact factor: 5.922

Review 6.  Intestinal lipid absorption and lipoprotein formation.

Authors:  M Mahmood Hussain
Journal:  Curr Opin Lipidol       Date:  2014-06       Impact factor: 4.776

7.  ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.

Authors:  Kai Yin; Duan-fang Liao; Chao-ke Tang
Journal:  Mol Med       Date:  2010-05-12       Impact factor: 6.354

8.  Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-07-08       Impact factor: 4.698

9.  BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein modulates ATP-binding cassette transporter A-1 trafficking and function.

Authors:  Sisi Lin; Chun Zhou; Edward Neufeld; Yu-Hua Wang; Suo-Wen Xu; Liang Lu; Ying Wang; Zhi-Ping Liu; Dong Li; Cuixian Li; Shaorui Chen; Kang Le; Heqing Huang; Peiqing Liu; Joel Moss; Martha Vaughan; Xiaoyan Shen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-06       Impact factor: 8.311

10.  Brefeldin A inhibits cholesterol efflux without affecting the rate of cellular uptake and re-secretion of apolipoprotein A-I in adipocytes.

Authors:  Philip B Verghese; Estela L Arrese; Alisha D Howard; Jose L Soulages
Journal:  Arch Biochem Biophys       Date:  2008-08-07       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.